Javascript must be enabled to continue!
Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia
View through CrossRef
BackgroundThe emergence of vancomycin resistant Enterococci (VRE) has alarmed the global community due to its tendency for colonization of the gastrointestinal tract. Human Immunodeficiency Virus (HIV) patients are colonized by vancomycin resistant Enterococci than other groups. The aim of this study was to determine the incidence of vancomycin resistant Enterococci and its associated factors among HIV infected patients on Anti-Retroviral Therapy (ART).MethodsInstitution based cross sectional study was conducted among HIV infected patients on ART at from June 1 to August 30, 2020. Socio-demographic and clinical data were collected by pre-tested structured questionnaire. Stool sample was collected and processed by standard microbiological techniques. Kirby Bauer Disc diffusion method was used to perform antimicrobial susceptibility testing. Data were entered by Epi data version 4.6.0.2 and analyzed by SPSS version 25. Bivariable and multivariable logistic regression model was used to analyze the association between dependent and independent variables. P-values in the multivariable analysis, adjusted odds ratio (AOR) and 95% confidence interval (CI) were used to determine the strength of association. P-value ≤0.05 was considered as significant.ResultsEnterococcispp was isolated on 123/200 (61.50%) patients. Among these isolates, the incidence of vancomycin resistant Enterococci was 11.4% [95% CI: (6.0–17.0)]. Antimicrobial susceptibility patterns againstEnterococcishowed highest rate of resistance to ampicillin (69.9%). Multidrug resistances were observed in 49.59% ofEnterococciisolates. Study participants who had prior antibioticexposurer more than two weeks [AOR = 7.35; 95% CI: (1.2144.64)] and hospitalization for the last six months [AOR = 5.68; 95% CI: (1.09 29.74)] were significantly associated with vancomycin resistantEnterococci.ConclusionsIn our study high incidence of vancomycin resistantEnterococciwas found. Previous exposure to antibiotics for more than two weeks and hospitalization for more than six months were significantly associated with vancomycin resistantEnterococci. The isolatedEnterococcihad variable degrees of resistance to commonly prescribed antibiotics. Therefore, periodic surveillance on antimicrobial resistance pattern, adhering to rational use of antibiotics and implementing infection prevention protocols may reduce colonization by VRE.
Title: Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia
Description:
BackgroundThe emergence of vancomycin resistant Enterococci (VRE) has alarmed the global community due to its tendency for colonization of the gastrointestinal tract.
Human Immunodeficiency Virus (HIV) patients are colonized by vancomycin resistant Enterococci than other groups.
The aim of this study was to determine the incidence of vancomycin resistant Enterococci and its associated factors among HIV infected patients on Anti-Retroviral Therapy (ART).
MethodsInstitution based cross sectional study was conducted among HIV infected patients on ART at from June 1 to August 30, 2020.
Socio-demographic and clinical data were collected by pre-tested structured questionnaire.
Stool sample was collected and processed by standard microbiological techniques.
Kirby Bauer Disc diffusion method was used to perform antimicrobial susceptibility testing.
Data were entered by Epi data version 4.
6.
2 and analyzed by SPSS version 25.
Bivariable and multivariable logistic regression model was used to analyze the association between dependent and independent variables.
P-values in the multivariable analysis, adjusted odds ratio (AOR) and 95% confidence interval (CI) were used to determine the strength of association.
P-value ≤0.
05 was considered as significant.
ResultsEnterococcispp was isolated on 123/200 (61.
50%) patients.
Among these isolates, the incidence of vancomycin resistant Enterococci was 11.
4% [95% CI: (6.
0–17.
0)].
Antimicrobial susceptibility patterns againstEnterococcishowed highest rate of resistance to ampicillin (69.
9%).
Multidrug resistances were observed in 49.
59% ofEnterococciisolates.
Study participants who had prior antibioticexposurer more than two weeks [AOR = 7.
35; 95% CI: (1.
2144.
64)] and hospitalization for the last six months [AOR = 5.
68; 95% CI: (1.
09 29.
74)] were significantly associated with vancomycin resistantEnterococci.
ConclusionsIn our study high incidence of vancomycin resistantEnterococciwas found.
Previous exposure to antibiotics for more than two weeks and hospitalization for more than six months were significantly associated with vancomycin resistantEnterococci.
The isolatedEnterococcihad variable degrees of resistance to commonly prescribed antibiotics.
Therefore, periodic surveillance on antimicrobial resistance pattern, adhering to rational use of antibiotics and implementing infection prevention protocols may reduce colonization by VRE.
Related Results
Vancomycin resistant enterococci gut Colonization and its associated factors among HIV infected patients on anti-Retro viral therapy in Ethiopia
Vancomycin resistant enterococci gut Colonization and its associated factors among HIV infected patients on anti-Retro viral therapy in Ethiopia
Abstract
BackgroundThe emergence of vancomycin resistant Enterococci (VRE) has alarmed the global infectious diseases community due to its tendency for colonization of the ...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
GLYCOPEPTIDE SUSCEPTIBILITY AMONG STAPHYLOCOCCI AND ENTEROCOCCI ISOLATES FROM SULAIMANI HEALTH LABORATORIES
GLYCOPEPTIDE SUSCEPTIBILITY AMONG STAPHYLOCOCCI AND ENTEROCOCCI ISOLATES FROM SULAIMANI HEALTH LABORATORIES
Background
Glycopeptide antibiotics are bactericidal agents that inhibit late stage bacterial cell wall peptidoglycan synthesis in Gram-positive bacteria. They are used for multir...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide
LY333328 is a semisynthetic N-alkyl derivative of LY264826, a naturally occurring structural analog of vancomycin. LY333328 was evaluated for its in vitro inhibitory and bactericid...
Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia
Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia
AbstractBackgroundToxoplasmosis, a zoonotic disease distributed worldwide, is an infection caused by the ubiquitous obligatory intracellular coccidian protozoan organism,Toxoplasma...
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Background: The HIV pandemic has attracted unprecedented scale-up in resources to curb its escalation and manage those afflicted. Although evidence from developing countries sugges...
Enhanced gene expression from retroviral vectors
Enhanced gene expression from retroviral vectors
Abstract
Background
Retroviruses are widely used to transfer genes to mammalian cells efficiently and stably. However, genetic elements required ...

